Trial intelligence / Profile preview

Deferoxamine mesylate for edema after intracerebral hemorrhage

ChiCTR-TRC-14004979Phase 4Recruiting

Sponsor
Peking University People's Hospital
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of deferoxamine in intracerebral hemorrhage (ICH) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Edema volume. Started Feb 2013; status: recruiting.

02

Drugs

deferoxamine
03

Conditions

intracerebral hemorrhage (ICH)

Beyond the preview

Go deeper on ChiCTR-TRC-14004979.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-14004979.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call